Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction

A growing body of evidence shows that altering the inflammatory response by alternative macrophage polarization is protective against complications related to acute myocardial infarction (MI). We have previously shown that oral azithromycin (AZM), initiated prior to MI, reduces inflammation and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Darraji, Ahmed, Donahue, Renée R., Tripathi, Himi, Peng, Hsuan, Levitan, Bryana M., Chelvarajan, Lakshman, Haydar, Dalia, Gao, Erhe, Henson, David, Gensel, John C., Feola, David J., Venditto, Vincent J., Abdel-Latif, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538891/
https://www.ncbi.nlm.nih.gov/pubmed/33024189
http://dx.doi.org/10.1038/s41598-020-73593-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538891/
https://www.ncbi.nlm.nih.gov/pubmed/33024189
http://dx.doi.org/10.1038/s41598-020-73593-0

Ejemplares similares